These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29850704)

  • 41. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
    Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
    Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATR-FTIR spectroscopy shows changes in ovarian cancer cells after incubation with novel organoamidoplatinum(ii) complexes.
    Al-Jorani K; Rüther A; Haputhanthri R; Deacon GB; Li HL; Cullinane C; Wood BR
    Analyst; 2018 Dec; 143(24):6087-6094. PubMed ID: 30457585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
    Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines.
    Quiroga AG; Pérez JM; López-Solera I; Montero EI; Masaguer JR; Alonso C; Navarro-Ranninger C
    J Inorg Biochem; 1998 Mar; 69(4):275-81. PubMed ID: 9654751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The design of cyclometalated iridium(iii)-metformin complexes for hypoxic cancer treatment.
    Yang J; Fang HJ; Cao Q; Mao ZW
    Chem Commun (Camb); 2021 Jan; 57(9):1093-1096. PubMed ID: 33434260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.
    Zhang J; Li L; Ji X; Sun J; Wang L; Zhang Y
    Eur J Med Chem; 2010 Jun; 45(6):2634-7. PubMed ID: 20153562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of Ag(I) camphor sulphonylimine complexes and assessment of their cytotoxic properties against cisplatin-resistant A2780cisR and A2780 cell lines.
    Cardoso JMS; Correia I; Galvão AM; Marques F; Carvalho MFNN
    J Inorg Biochem; 2017 Jan; 166():55-63. PubMed ID: 27835775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.
    Dhar S; Lippard SJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22199-204. PubMed ID: 20007777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.
    Xue X; You S; Zhang Q; Wu Y; Zou GZ; Wang PC; Zhao YL; Xu Y; Jia L; Zhang X; Liang XJ
    Mol Pharm; 2012 Mar; 9(3):634-44. PubMed ID: 22289032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combining anti-cancer drugs with artificial sweeteners: synthesis and anti-cancer activity of saccharinate (sac) and thiosaccharinate (tsac) complexes cis-[Pt(sac)2(NH3)2] and cis-[Pt(tsac)2(NH3)2].
    Al-Jibori SA; Al-Jibori GH; Al-Hayaly LJ; Wagner C; Schmidt H; Timur S; Baris Barlas F; Subasi E; Ghosh S; Hogarth G
    J Inorg Biochem; 2014 Dec; 141():55-57. PubMed ID: 25216367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoterpenes as drug shuttles: cytotoxic (6-aminomethylnicotinate)dichloridoplatinum(II) complexes with potential to overcome cisplatin resistance.
    Schobert R; Biersack B; Dietrich A; Grotemeier A; Müller T; Kalinowski B; Knauer S; Voigt W; Paschke R
    J Med Chem; 2007 Mar; 50(6):1288-93. PubMed ID: 17328536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.
    Mihajlović LE; Savić A; Poljarević J; Vučković I; Mojić M; Bulatović M; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Stošić-Grujičić S; Miljković Đ; Grgurić-Šipka S; Sabo TJ
    J Inorg Biochem; 2012 Apr; 109():40-8. PubMed ID: 22369771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjusting the lipid-water distribution coefficient of iridium(III) complexes to enhance the cellular penetration and treatment efficacy to antagonize cisplatin resistance in cervical cancer.
    Huang W; Chen Z; Hou L; Feng P; Li Y; Chen T
    Dalton Trans; 2020 Aug; 49(33):11556-11564. PubMed ID: 32716436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
    Margiotta N; Savino S; Gandin V; Marzano C; Natile G
    ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A recombinant platform to characterize the role of transmembrane protein hTMEM205 in Pt(II)-drug resistance and extrusion.
    Gallenito MJ; Qasim TS; Tutol JN; Prakash V; Dodani SC; Meloni G
    Metallomics; 2020 Oct; 12(10):1542-1554. PubMed ID: 32789331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
    Zák F; Turánek J; Kroutil A; Sova P; Mistr A; Poulová A; Mikolin P; Zák Z; Kasná A; Záluská D; Neca J; Sindlerová L; Kozubík A
    J Med Chem; 2004 Jan; 47(3):761-3. PubMed ID: 14736257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt(NH3)2Cl]+ units bridged by 4,4'-dipyridyl selenides or sulfides.
    Zhao G; Lin H; Zhu S; Sun H; Chen Y
    Anticancer Drug Des; 1998 Oct; 13(7):769-77. PubMed ID: 9807161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro evaluation of the enantiomeric R- and S-1,1'-binaphthyl-2,2'-diaminodichlorido-Pt(ii) complexes in human Burkitt lymphoma cells: emphasis on cellular accumulation, cytotoxicity, DNA binding, and ability to induce apoptosis.
    Sørensen BH; Werth P; Lambert IH; Bednarski PJ
    Metallomics; 2018 Feb; 10(2):323-336. PubMed ID: 29333543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
    Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
    Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.